258 related articles for article (PubMed ID: 31155465)
1. Controversies in antenatal corticosteroids.
Shanks AL; Grasch JL; Quinney SK; Haas DM
Semin Fetal Neonatal Med; 2019 Jun; 24(3):182-188. PubMed ID: 31155465
[TBL] [Abstract][Full Text] [Related]
2. Use of Antenatal Corticosteroids in Preterm Prelabor Rupture of Membranes.
Battarbee AN
Obstet Gynecol Clin North Am; 2020 Dec; 47(4):587-594. PubMed ID: 33121646
[TBL] [Abstract][Full Text] [Related]
3. Antenatal corticosteroids after 34 weeks' gestation: Do we have the evidence?
Groom KM
Semin Fetal Neonatal Med; 2019 Jun; 24(3):189-196. PubMed ID: 31029555
[TBL] [Abstract][Full Text] [Related]
4. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.
Crowther CA; Haslam RR; Hiller JE; Doyle LW; Robinson JS;
Lancet; 2006 Jun; 367(9526):1913-9. PubMed ID: 16765760
[TBL] [Abstract][Full Text] [Related]
5. Optimizing antenatal corticosteroid therapy.
Kemp MW; Schmidt AF; Jobe AH
Semin Fetal Neonatal Med; 2019 Jun; 24(3):176-181. PubMed ID: 31103447
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.
Vermillion ST; Soper DE; Bland ML; Newman RB
Am J Obstet Gynecol; 2000 Oct; 183(4):925-9. PubMed ID: 11035339
[TBL] [Abstract][Full Text] [Related]
7. Antenatal corticosteroid therapy: current strategies and identifying mediators and markers for response.
Falah N; Haas DM
Semin Perinatol; 2014 Dec; 38(8):528-33. PubMed ID: 25256192
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial.
Gyamfi-Bannerman C; Zupancic JAF; Sandoval G; Grobman WA; Blackwell SC; Tita ATN; Reddy UM; Jain L; Saade GR; Rouse DJ; Iams JD; Clark EAS; Thorp JM; Chien EK; Peaceman AM; Gibbs RS; Swamy GK; Norton ME; Casey BM; Caritis SN; Tolosa JE; Sorokin Y; VanDorsten JP;
JAMA Pediatr; 2019 May; 173(5):462-468. PubMed ID: 30855640
[TBL] [Abstract][Full Text] [Related]
9. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials.
Saccone G; Berghella V
BMJ; 2016 Oct; 355():i5044. PubMed ID: 27733360
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of preterm birth complications by antenatal corticosteroid administration].
Schmitz T
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
Modanlou HD; Beharry K; Padilla G; Iriye B
J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
[TBL] [Abstract][Full Text] [Related]
12. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
Kamath-Rayne BD; Rozance PJ; Goldenberg RL; Jobe AH
Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
[TBL] [Abstract][Full Text] [Related]
13. Amniocentesis compared with antenatal corticosteroids prior to early term scheduled cesarean delivery.
Zafman KB; Fox NS
J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3571-3576. PubMed ID: 29681180
[No Abstract] [Full Text] [Related]
14. Do maternal demographics and prenatal history impact the efficacy of betamethasone therapy for threatened preterm labor?
Kinney MT; Quinney SK; Trussell HK; Silva LL; Ibrahim SA; Haas DM
BMC Pregnancy Childbirth; 2021 Jun; 21(1):442. PubMed ID: 34167497
[TBL] [Abstract][Full Text] [Related]
15. [The corticosteroid therapy of premature rupture of the fetal membranes].
Ruseva R; Dimitrov E; Slŭncheva B; Iarŭkova N
Akush Ginekol (Sofiia); 1999; 38(4):5-7. PubMed ID: 10726340
[TBL] [Abstract][Full Text] [Related]
16. Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: an evaluation of neonatal outcomes.
Kamath-Rayne BD; DeFranco EA; Marcotte MP
Obstet Gynecol; 2012 May; 119(5):909-16. PubMed ID: 22525901
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of strategies regarding management of imminent preterm delivery before 32 weeks of gestation: a regional cohort study among 1375 women in the Netherlands.
Boesveld M; Oudijk MA; Koenen SV; Brouwers HA; Van Beek E; Boon J; Drogtrop A; Euser R; Evers IM; Fiedeldeij CA; Heida KY; Huisjes AJ; Muijsers GJ; Schierbeek JM; Kwee A
Am J Obstet Gynecol; 2015 Mar; 212(3):348.e1-7. PubMed ID: 25447962
[TBL] [Abstract][Full Text] [Related]
18. Guideline for the use of antenatal corticosteroids for fetal maturation.
Miracle X; Di Renzo GC; Stark A; Fanaroff A; Carbonell-Estrany X; Saling E;
J Perinat Med; 2008; 36(3):191-6. PubMed ID: 18576926
[TBL] [Abstract][Full Text] [Related]
19. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
; Reddy UM; Deshmukh U; Dude A; Harper L; Osmundson SS
Am J Obstet Gynecol; 2021 Nov; 225(5):B36-B42. PubMed ID: 34363784
[TBL] [Abstract][Full Text] [Related]
20. The use and abuse of steroids in perinatal medicine.
Rajadurai VS; Tan KH
Ann Acad Med Singap; 2003 May; 32(3):324-34. PubMed ID: 12854376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
